Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Customising Cancer Treatment - The Challenge Of Genetics

22.12.2004


At the Norwegian Radium Hospital in Oslo, scientists are approaching methods that will improve the patients’ chances of survival and reduce unnecessary treatment.

The cancer treatment of today involves a lot of trial and error. Cancer cells that have started to grow uncontrollably, must be stopped. We use different kinds of medicinal drugs to stop cell growth and induce apoptosis, i.e. make the cells commit suicide. However, nobody knows whether or not the chosen form of medication has an effect on the patient until it has been tried out over a period of time. There is always a risk of losing time, especially if the tumour is big and has to be treated with medication before it is possible to perform surgery.

The problem with cancer treatment today is that it does not consider the genetic variety of human beings and the fact that each individual tumour is genetically unique.



"By giving the same medication to all patients that have the same diagnosis, there is a risk that some may die in the course of the disease because the drug is not working, while others may be poisoned by excessive doses. Although most patients will recover, it is not easy to predict who will recover and who will not," says Vessela Nedelcheva Kristensen.

By conducting meticulous research and with the help of the latest, state-of-the-art instrument called Nanochip Workstation, Nedelcheva Kristensen and her research team are trying to identify the genes that have an influence on how anti-cancer drugs work on each patient. With grants from the Research Council of Norway’s National Programme for Research in Functional Genomics, FUGE, this young scientist takes part in research that may revolutionise cancer treatment. The researchers take samples from each tumour and analyse them, and they take blood samples from the patients to analyse their genetic sensitivity to an anti-cancer drug. This sensitivity varies according to each individual.

"By genetically testing each tumour, we may be able to say which form of treatment suits each patient. This is groundwork for individually tailored cancer treatment," she says.

By conducting meticulous research and with the help of the latest, state-of-the-art instrument called Nanochip Workstation, Nedelcheva Kristensen and her research team are trying to identify the genes that have an influence on how anti-cancer drugs work on each patient. With grants from the Research Council of Norway’s National Programme for Research in Functional Genomics, FUGE, this young scientist takes part in research that may revolutionise cancer treatment. The researchers take samples from each tumour and analyse them, and they take blood samples from the patients to analyse their genetic sensitivity to an anti-cancer drug. This sensitivity varies according to each individual.

"By genetically testing each tumour, we may be able to say which form of treatment suits each patient. This is groundwork for individually tailored cancer treatment," she says.

Thomas Evensen | alfa
Further information:
http://www.forskningsradet.no/forport/application?lang=en_UK

More articles from Health and Medicine:

nachricht Usher syndrome: Gene therapy restores hearing and balance
25.09.2017 | Institut Pasteur

nachricht MRI contrast agent locates and distinguishes aggressive from slow-growing breast cancer
25.09.2017 | Case Western Reserve University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The fastest light-driven current source

Controlling electronic current is essential to modern electronics, as data and signals are transferred by streams of electrons which are controlled at high speed. Demands on transmission speeds are also increasing as technology develops. Scientists from the Chair of Laser Physics and the Chair of Applied Physics at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) have succeeded in switching on a current with a desired direction in graphene using a single laser pulse within a femtosecond ¬¬ – a femtosecond corresponds to the millionth part of a billionth of a second. This is more than a thousand times faster compared to the most efficient transistors today.

Graphene is up to the job

Im Focus: LaserTAB: More efficient and precise contacts thanks to human-robot collaboration

At the productronica trade fair in Munich this November, the Fraunhofer Institute for Laser Technology ILT will be presenting Laser-Based Tape-Automated Bonding, LaserTAB for short. The experts from Aachen will be demonstrating how new battery cells and power electronics can be micro-welded more efficiently and precisely than ever before thanks to new optics and robot support.

Fraunhofer ILT from Aachen relies on a clever combination of robotics and a laser scanner with new optics as well as process monitoring, which it has developed...

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Nerves control the body’s bacterial community

26.09.2017 | Life Sciences

Four elements make 2-D optical platform

26.09.2017 | Physics and Astronomy

Goodbye, login. Hello, heart scan

26.09.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>